FR EN

Back


18/06/2019
BioSerenity closes €65m funding to extend its activity into the US
Specialising in remote diagnostic solutions for several chronic disease areas, this medical technology company already operates with more than two hundred healthcare facilities around the globe, helping them to perform more efficient medical procedures. With this financing the startup aims to accelerate growth, especially internationally, and expand current IoT and AI solutions.

Download the pdf file





X

X

X

Eurazeo

One Group, One brand

On April 28, 2021, Idinvest Partners, a wholly-owned subsidiary of Eurazeo since 2020, changed its name to reflect its integral position in the Group.
All activities in the Private Equity, Private Debt and Real Assets businesses now share the single Eurazeo brand.

Find all the information on the Group, its businesses and its commitments on the eurazeo.com website.

www.eurazeo.com